Cargando…
Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem
Prostate cancer is the most frequent malignant tumor in male. Despite its incidence increased in the last few years, the mortality is gradually decreasing, even in patients with metastatic prostate cancer (mPC). Unfortunately, prolongation of survival leads to the exhaustion of therapeutic chances....
Autores principales: | La Vecchia, Maria, Galanti, Daniele, Fazio, Ivan, Paratore, Rosario, Borsellino, Nicolò |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035953/ https://www.ncbi.nlm.nih.gov/pubmed/35529294 http://dx.doi.org/10.1159/000522086 |
Ejemplares similares
-
Megestrol acetate in cachexia and anorexia
por: Yeh, Shing-shing, et al.
Publicado: (2006) -
Safety of Megestrol Acetate in Palliating Anorexia-Cachexia Syndrome in Patients with Castration-Resistant Prostate Cancer
por: Hong, Sungwoo, et al.
Publicado: (2013) -
Metastatic Castration-Resistant Prostate Cancer: Two Case Reports of Dramatic Response with Abiraterone Acetate in Patients Heavily Pretreated with Chemotherapy
por: Dupuy, Laura, et al.
Publicado: (2011) -
Megestrol Acetate-Induced Symptomatic Hypogonadism in a Male Patient
por: Munshi, Lubna Bashir, et al.
Publicado: (2018) -
Megestrol acetate for cachexia–anorexia syndrome. A systematic review
por: Ruiz‐García, Vicente, et al.
Publicado: (2018)